Submitted by shnsAdmin on Mon, 09/26/2016 - 4:44pm
The campaign to reduce barriers to abortion access in Canada continues to face obstacles. A story published today in The Globe & Mail online reveals that the medical abortion drug Mifegymiso may not be covered by most provincial drug plans when it becomes available later this year.
Without drug coverage, people who wish to take Mifegymiso will have to pay anywhere from $270 to $300 out of pocket.
According to the Globe: